Your session is about to expire
← Back to Search
Cardiometabolic Screening for Breast Cancer Survivors
Study Summary
This trial is testing a screening program to catch early signs of diabetes, high cholesterol, and other heart disease risk factors in breast cancer survivors. The goal is to get patients help and treatment before these conditions worsen.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am receiving breast cancer treatment at Johns Hopkins or its associated clinics.I finished my cancer treatment over 3 months ago.I have been diagnosed with early stage breast cancer.My breast cancer has spread to other parts of my body.
- Group 1: Early stage breast cancer survivors
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies left in this clinical research project?
"Affirmative. Clinicaltrials.gov confirms that this clinical trial, originally posted on June 3rd 2022, is actively searching for participants to enroll. Approximately 450 patients are needed from one medical centre."
How many individuals are being administered therapies as part of this investigation?
"Yes, the data on clinicaltrials.gov reveals that this ongoing study is actively recruiting participants. It was initially posted in June 3rd 2022 and last updated 16th of the same month. Up to 450 individuals are sought after from a single medical centre."
To what end is this experiment striving?
"This trial, estimated to take three years, will focus on quantifying the prevalence of diabetes. Secondary goals include determining the number of breast cancer patients with cardiovascular risk factors (tobacco use) and referrals for individuals with pre-diabetes. Lastly, researchers aim to compare hyperlipidemia levels between women with breast cancer and healthy controls by accessing a national database."
Share this study with friends
Copy Link
Messenger